Radiomics and clinical data predict pseudoprogression after radiotherapy in high-grade glioma - Top-Institutions - MDSpire

Predictive Models Utilizing Radiomics and Clinical Information for Assessing Pseudoprogression Following Radiotherapy in High-Grade Glioma

  • By

  • Jiang Zhou

  • Zhang Danmeng

  • Yang Hui

  • Xu Zhuohua

  • Wei Mingjing

  • Lu Ying

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Medical Research Ethics Committee of Liuzhou Workers’ Hospital
    Medical Research Ethics Committee of Liuzhou Workers’ Hospital

    Liuzhou, Guangxi

    Key Differentiators

    • Oncology

  • #2

    Swedish University Hospitals
    Swedish University Hospitals

    Stockholm, Sweden

    Key Differentiators

    • Oncology

  • #3

    Leeds Teaching Hospitals NHS Trust
    Leeds Teaching Hospitals NHS Trust

    Leeds, UK

    Key Differentiators

    • Oncology

  • #4

    The Christie NHS Foundation Trust
    The Christie NHS Foundation Trust

    Manchester, UK

    Key Differentiators

    • Oncology

  • #5

    Hospital Clínico Universitario de Valencia
    Hospital Clínico Universitario de Valencia

    Valencia, Spain

    Key Differentiators

    • Oncology

Original Source(s)

Radiomics and clinical data predict pseudoprogression after radiotherapy in high-grade glioma

  • by Jiang Zhou, Zhang Danmeng, Yang Hui, Xu Zhuohua, Wei Mingjing, Lu Ying

  • July 20, 2026

Related Content

STMN1 expression is associated with chemotherapy and immunotherapy efficacy in biliary tract cancer

Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway

Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management